Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
AMIRAVOResearch Library
Cycle-length evidence

Bronchogen cycle length: what human studies ran

Not approved — research use onlyCPreclinical research
Short answer: there is no established Bronchogen cycle length, and we found no human studies that report one.

Treatment and follow-up in human studies

No human study durations are recorded.

What has not been tested

  • On-and-off schedules or breaks between courses.
  • Repeated courses and long-term exposure beyond the periods listed.
  • Bronchogen combined with other compounds, unless a study above says so.

Frequently asked questions

Is there an established Bronchogen cycle length?
No. We found no human studies that report a treatment duration for Bronchogen.
What is the longest human study of Bronchogen?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
Bronchogen dosing reference Full research page

References

  1. Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostability Bull Exp Biol Med. 2011
  2. Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology Bull Exp Biol Med. 2015
  3. Short Exogenous Peptides Regulate Expression of CLE, KNOX1, and GRF Family Genes in Nicotiana tabacum Biochemistry (Mosc). 2017
  4. [Antiinflammatory and regenerative effect of peptide therapy in the model of obstructive lung pathology] Ross Fiziol Zh Im I M Sechenova. 2017
  5. Peptides tissue-specifically stimulate cell differentiation during their aging Bull Exp Biol Med. 2012
  6. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA Biochemistry (Mosc). 2011
  7. Drugs@FDA: FDA-Approved Drugs (search of approved applications) FDA Drugs@FDA / openFDA drug/drugsfda. 2026
  8. DailyMed label search (structured product labels) NLM DailyMed. 2026
  9. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the FD&C Act, updated May 14, 2026 FDA. 2026
  10. World Anti-Doping Code International Standard: Prohibited List 2026 WADA. 2026